Cold agglutinin disease (CAD) disease negatively affects a variety of aspects of daily living, with patients often experiencing…
Articles by Marisa Wexler, MS
People with non-Hodgkin’s lymphoma (NHL) — a type of blood cancer — that co-occurs with autoimmune hemolytic anemia…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
The case of an infant who developed cold agglutinin disease (CAD) shortly after being vaccinated suggests that intravenous…
Treatment with the cancer immunotherapy Keytruda (pembrolizumab) can lead to the development of cold agglutinin disease (CAD), the…
Therapies that contain Rituximab may be effective for people with cold agglutinin disease (CAD), a study suggests. The…
A case report from Michigan suggests that coronavirus disease 2019 (COVID-19) could cause cold agglutinin disease (CAD). Results showed…
The U.S. Food and Drug Administration (FDA) is giving priority review to Sanofi’s request that sutimlimab be approved to…
The investigational therapy sutimlimab prevented hemolysis, significantly increased hemoglobin, and improved the quality of life in patients with cold agglutinin…